Altmetric

Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes.

File Description SizeFormat 
Solimena et al 2017 Diabetologia.pdfAccepted version6.64 MBAdobe PDFView/Open
10.1007%2Fs00125-017-4500-3.pdfPublished version2 MBAdobe PDFView/Open
Title: Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes.
Authors: Solimena, M
Schulte, AM
Marselli, L
Ehehalt, F
Richter, D
Kleeberg, M
Mziaut, H
Knoch, K-P
Parnis, J
Bugliani, M
Siddiq, A
Jörns, A
Burdet, F
Liechti, R
Suleiman, M
Margerie, D
Syed, F
Distler, M
Grützmann, R
Petretto, E
Moreno-Moral, A
Wegbrod, C
Sönmez, A
Pfriem, K
Friedrich, A
Meinel, J
Wollheim, CB
Baretton, GB
Scharfmann, R
Nogoceke, E
Bonifacio, E
Sturm, D
Meyer-Puttlitz, B
Boggi, U
Saeger, H-D
Filipponi, F
Lesche, M
Meda, P
Dahl, A
Wigger, L
Xenarios, I
Falchi, M
Thorens, B
Weitz, J
Bokvist, K
Lenzen, S
Rutter, GA
Froguel, P
Von Bülow, M
Ibberson, M
Marchetti, P
Item Type: Journal Article
Abstract: AIMS/HYPOTHESIS: Pancreatic islet beta cell failure causes type 2 diabetes in humans. To identify transcriptomic changes in type 2 diabetic islets, the Innovative Medicines Initiative for Diabetes: Improving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in Diabetes (IMIDIA) consortium ( www.imidia.org ) established a comprehensive, unique multicentre biobank of human islets and pancreas tissues from organ donors and metabolically phenotyped pancreatectomised patients (PPP). METHODS: Affymetrix microarrays were used to assess the islet transcriptome of islets isolated either by enzymatic digestion from 103 organ donors (OD), including 84 non-diabetic and 19 type 2 diabetic individuals, or by laser capture microdissection (LCM) from surgical specimens of 103 PPP, including 32 non-diabetic, 36 with type 2 diabetes, 15 with impaired glucose tolerance (IGT) and 20 with recent-onset diabetes (<1 year), conceivably secondary to the pancreatic disorder leading to surgery (type 3c diabetes). Bioinformatics tools were used to (1) compare the islet transcriptome of type 2 diabetic vs non-diabetic OD and PPP as well as vs IGT and type 3c diabetes within the PPP group; and (2) identify transcription factors driving gene co-expression modules correlated with insulin secretion ex vivo and glucose tolerance in vivo. Selected genes of interest were validated for their expression and function in beta cells. RESULTS: Comparative transcriptomic analysis identified 19 genes differentially expressed (false discovery rate ≤0.05, fold change ≥1.5) in type 2 diabetic vs non-diabetic islets from OD and PPP. Nine out of these 19 dysregulated genes were not previously reported to be dysregulated in type 2 diabetic islets. Signature genes included TMEM37, which inhibited Ca2+-influx and insulin secretion in beta cells, and ARG2 and PPP1R1A, which promoted insulin secretion. Systems biology approaches identified HNF1A, PDX1 and REST as drivers of gene co-expression modules correlated with impaired insulin secretion or glucose tolerance, and 14 out of 19 differentially expressed type 2 diabetic islet signature genes were enriched in these modules. None of these signature genes was significantly dysregulated in islets of PPP with impaired glucose tolerance or type 3c diabetes. CONCLUSIONS/INTERPRETATION: These studies enabled the stringent definition of a novel transcriptomic signature of type 2 diabetic islets, regardless of islet source and isolation procedure. Lack of this signature in islets from PPP with IGT or type 3c diabetes indicates differences possibly due to peculiarities of these hyperglycaemic conditions and/or a role for duration and severity of hyperglycaemia. Alternatively, these transcriptomic changes capture, but may not precede, beta cell failure.
Issue Date: 28-Nov-2017
Date of Acceptance: 29-Aug-2017
URI: http://hdl.handle.net/10044/1/54338
DOI: https://dx.doi.org/10.1007/s00125-017-4500-3
ISSN: 0012-186X
Publisher: Springer Verlag
Start Page: 641
End Page: 657
Journal / Book Title: Diabetologia
Volume: 61
Issue: 3
Copyright Statement: © The Author(s) 2017. This article is an open access publication
Keywords: Beta cell
Biobank
Diabetes
Gene expression
Insulin secretion
Islet
Laser capture microdissection
Organ donor
Pancreatectomy
Systems biology
1103 Clinical Sciences
1114 Paediatrics And Reproductive Medicine
1117 Public Health And Health Services
Endocrinology & Metabolism
Publication Status: Published
Appears in Collections:Clinical Sciences
Molecular Sciences
Department of Medicine
Faculty of Medicine
Epidemiology, Public Health and Primary Care



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx